Posted by AGORACOM-JC
at 9:00 AM on Thursday, March 14th, 2019
RECENT HIGHLIGHTS
SIGNED A COOPERATION AGREEMENT FOR THE EMERGENCY MEDICAL SERVICES MARKETS
Will enable them to provide real-time monitoring of patients while in transit on the ground or in the air.
CHUSJ is one of the top 10 mother-child hospitals in the World, with over 3500 births a year.
Has over 1500 nurses, over 500 Doctors and over 200 researchers on staff.
COMPLETED SALE OF FIVE STAR-A.D.S SYSTEMS TO ALMASRIA UNIVERSAL AIRLINES
Announced that AlMasria Universal Airlines of Egypt has decided to
proceed with the installation and activation of the STAR-A.D.S.® System
across all five (5) of its current aircraft fleet, which includes A-320,
A-321, A330 and B737 aircraft.
BOMBARDER JOINT RESEARCH AND DEVELOPMENT PROGRAM
Joint research and development program with Bombardier and other
industrials and universities of Canada is progressing very positively.
The STAR-A.D.S. ® system which is at the heart of the program, after
having been validated and extensively used by the aircraft
manufacturer, has now been transferred to another flight test vehicle to
complete the flight testing and the data collection.
EMERGENCY MEDICAL SERVICES APPLICATIONS
Star’s Land System Aided Medical Monitoring system for ground
ambulance applications has undergone a series of demonstrations by a
care organization in North America.
Its airborne parent system, the In-Flight System Aided Medical
Monitoring system (STAR-ISAMM™â€), has now been demonstrated to several
stakeholders of the commercial and civil air ambulance market.
CHECK OUT OUR RECENT INTERVIEW
FULL DISCLOSURE: Star Navigation Systems Group Ltd. is an advertising client of AGORA Internet Relations Corp.
Innovation Continues as the FDA Clears CardioComm Solutions’ Novel
ECG Smartphone App and Heartcheck(TM) Device for Direct to Consumer
Sales Read More
Received approval from the US Food and Drug Administration for the
over-the-counter sales and marketing of their device agnostic GEMS™
Mobile smartphone app and their newest handheld, heart rhythm monitor,
the HeartCheckTM CardiBeat
Both have been cleared as a Class II medical device and are available for sale direct to consumers.
CardioComm Solutions’ HeartCheck(TM) Device Enters Final FDA Review Phase Read More
Completed a request for additional information from the US Food and
Drug Administration (“FDA”) for the Company’s premarket notification
510(k), Class II medical device clearance application for the
HeartCheck™ CardiBeat and GEMS™ Mobile Application.
Company had submitted a letter of revocation of their supplementary
information submission on December 26, 2018 in compliance with the FDA’s
directive
CardioComm Solutions’ HeartCheck(TM) CardiBeat and Smart Phone App Enter Final Stage of FDA 510(k) Review Read More
Market Release of HeartCheck(TM) CardiBeat and GEMS(TM) Mobile Application Set For Early 2019
Completed its response to the USA Food and Drug Administration for
additional information following the Company’s filing of its premarket
notification 510(k)
Class II medical device clearance application for the HeartCheck™ CardiBeat and GEMS™ Mobile Application
HeartCheck™ CardiBeat is the second of several planned Bluetooth-enabled ECG recording devices to be marketed by the Company
An Innovator in the Mobile ECG Industry
Company Accolades
FULL DISCLOSURE: CardioComm Solutions Inc. is an advertising client of AGORA Internet Relations Corp.
Posted by AGORACOM-JC
at 1:53 PM on Monday, March 4th, 2019
WHY NORTHBUD FARMS?
Canadian regulatory door for CIP (Cannabinoid Infused Products) is opening this year As shown in other legal jurisdictions (Colorado, Washington, Nevada, California)
Infused products sector has become the highest margin segment of the industry
Positioned to be a raw input producer for this space
Currently working with multiple food,
beverage and science companies to provide safe standardized cannabinoid
infused raw inputs for large scale GMP manufacturing of products
Announced Creation of “1017†Distribution and Signing of a LOI to Acquire Janey’s Cannabis Line
THE OPPORTUNITY
Acquired late stage ACMPR applicant GrowPros MMP from Tetra Bio-Pharma (TSXV: TBP)
GrowPros MMP application was submitted in November 2014 and is currently in the ‘Confirmation of Readiness’ stage.
Announced the amendment of its licence application to add 500K SQ. FT. of outdoor cultivation area
Posted by AGORACOM-JC
at 11:20 AM on Friday, March 1st, 2019
Investment Highlights
Kenbridge property has a measured and indicated resource of 7.14 million tonnes at 0.62% nickel, 0.33% copper
17.5 (21.8 fully diluted) percent equity stake in Eloro Resources and 2 percent NSR in their La Victoria property
Kenbridge Ni Project (ON, Canada)
Advanced stage deposit remains open in three directions, is
equipped with a 623m deep shaft and has never been mined.
Preliminary Economic Assessment completed and updated returned robust project economics and operating costs including a NPV of C$253M and cash costs of US$3.47/lb of nickel net of copper credits.
Plans for Kenbridge include updating PEA,
advancing the project through to feasibility and exploring the open
mineralization at depth
FULL DISCLOSURE: Tartisan Nickel Corp. is an advertising client of AGORA Internet Relations Corp.
Posted by AGORACOM-JC
at 12:33 PM on Monday, February 25th, 2019
SPONSOR: Bougainville
Ventures Inc (CSE: BOG) Converting irrigated farmland to
greenhouse-equipped farmland. Bougainville does not “touch the plantâ€
and only provides agricultural infrastructure as a landlord for
licensed marijuana growers. Click here for more info.
BOG:CSE —————————————
Nearly 1 in 6 Canadians Have Used Marijuana Since Recreational Pot Was Legalized
New data from Statistics Canada offers an inside look at cannabis consumption rates based on province, gender, and age.
The sky seems to be the limit for the legal marijuana industry.
According to the most bullish forecast from Wall Street investment firm Cowen Group, the legal weed industry could surpass soda in global sales by 2030 and generate $75 billion in yearly revenue.
More immediately, a co-authored report from Arcview Market Research and BDS Analytics has called for 38% global sales growth in 2019 to $16.9 billion.
Sean Williams Feb 23, 2019 at 10:51AM
The sky seems to be the limit for the legal marijuana industry.
According to the most bullish forecast from Wall Street investment firm Cowen Group, the legal weed industry could surpass soda in global sales by 2030 and generate $75 billion in yearly revenue.
More immediately, a co-authored report from Arcview Market Research and
BDS Analytics has called for 38% global sales growth in 2019 to $16.9
billion. No matter how you analyze the data, that’s a lot of green to go
around; and it’s a big reason why pot stocks have been virtually
unstoppable since the year began.
Although the United States would represent the largest cannabis
market in the world by sales if it were legalized at the federal level,
it’s our northerly neighbor Canada that’s leading the charge on
marijuana reform. Having become the first industrialized country in the world,
and only second overall behind Uruguay, to legalize adult-use pot in
October, Canada looks to be on track for an estimated $5.9 billion in
annual sales by 2022.
Image source: Getty Images.
An inside look at the average Canadian cannabis user
But just how quickly are Canadians adapting to this legalized
environment? For that answer, I turn to Statistics Canada, the national
statistics office that gathers information on Canada’s economy,
environment, and society.
Recently (as of Feb. 21, 2019), Statistics Canada released self-reported data
on consumers’ use of cannabis over the past three months. As a
refresher, marijuana legalization occurred roughly four months ago,
although the first month was a supply-side disaster. That means the past
three months of use should give us a really good idea of what the
typical Canadian consumer looks like.
According to the data, which Statistics Canada will continue to
update, 15.4% of all citizens, or nearly 1 out of 6 Canadians, have used
cannabis over the past three months. As you can imagine, usage
statistics tend to vary by region, gender, and age. For instance, Quebec
had the lowest percentage of people using marijuana over the past three
months (13.6%), while the lesser-populated Nova Scotia had the highest
percentage by far at 21.6%. Newfoundland and Labrador and New Brunswick
were also significantly above the national self-reported average in
three-month use rates.
In terms of gender, men were significantly more likely than women (19.4% vs. 11.3%) to have consumed cannabis recently.
Finally, as you might expect, pot use over the past three months was
considerably higher among younger people than older folks. Overall,
27.4% of Canadians aged 15 to 24 and 23.2% of those aged 25 to 34 used
cannabis over the past three months. Meanwhile, just 5.2% of seniors
aged 65 and up and 10.4% of Canadians aged 55 to 64 used weed recently.
Even though the older generation has more disposable income, it’s these
younger adults that are the future of the legal weed industry.
Image source: Getty Images.
Cannabis consumption rates are likely to rise — here’s why
Although there were no major surprises here, there are some relatively interesting takeaways to be made.
For example, an average use rate of just 15.4% might seem rather low,
but it’s not factoring in two pretty important catalysts. First,
there’s the fact that marijuana growers are still in the early stages of
ramping up their production. Aurora Cannabis (NYSE:ACB), which is my selection to lead the country with 700,000 kilograms of peak annual production,
is only producing at an annual run rate of 120,000 kilos right now. By
the end of the current calendar quarter, Aurora Cannabis should be
yielding more than 150,000 kilos annually, but it’s going to take
perhaps 12 to 24 more months before Aurora is operating on all
cylinders. When consumers have access to ample demand and the per-gram
price for dried cannabis flower comes down a bit, we’re liable to see
usage rates increase.
The second catalyst is the expected legalization of new consumption
options by this fall. When the Cannabis Act was signed into law last
June, and legal product sales commenced on Oct. 17, 2018, it only
included dried flower, cannabis oil, and sprays. Alternative products
such as edibles and cannabis-infused beverages aren’t yet legal.
That, however, is expected to change by no later than Oct. 17, 2019,
according to an outline presented by Health Canada. Edibles and infused
beverages containing cannabidiol (CBD), the nonpsychoactive cannabinoid
best known for its medical benefits, are expected to be especially
important in luring in new users.
The provincial-use data is also interesting in that it highlights one potential under-the-radar grower: OrganiGram Holdings (NASDAQOTH:OGRMF). The New Brunswick-based OrganiGram is the only Atlantic grower expected to yield more than 100,000 kilograms
per year when at full production capacity. Its geographic location
gives it competitive advantages in New Brunswick, Nova Scotia, and
Newfoundland and Labrador. Sure, these are far less populated regions
than, say, Ontario or Quebec, but it nevertheless allows OrganiGram a
foothold in these potentially higher-use provinces and territories.
OrganiGram was already a value stock among its peers, but it’s now that
much more intriguing following the release of this data.
Image source: Getty Images.
I believe this data also demonstrates the scope of opportunity awaiting Shopify (NYSE:SHOP) and its e-commerce platform. A number of large growers and provinces, including Ontario,
have chosen to utilize Shopify’s sales platform for online and
brick-and-mortar sales. Aside from simply being the sales platform of
choice, Shopify offers marijuana companies purchasing data on consumers
for pretty much the first time ever. With this being a cash-dominated
industry, it’s been virtually impossible for growers and retailers to
understand their customer base. With Shopify, this is going to change,
and both producers and retailers will be able to more directly target
consumers.
Ultimately, the legal weed industry is still in its infancy in
Canada. That means we’re liable to see this data shift as Health Canada
adjusts the boundaries of what’s legal and growers and retailers come to
better understand their customers.
Posted by AGORACOM-JC
at 11:53 AM on Monday, February 25th, 2019
RECENT HIGHLIGHTS
SIGNED A COOPERATION AGREEMENT FOR THE EMERGENCY MEDICAL SERVICES MARKETS
Will enable them to provide real-time monitoring of patients while in transit on the ground or in the air.
CHUSJ is one of the top 10 mother-child hospitals in the World, with over 3500 births a year.
Has over 1500 nurses, over 500 Doctors and over 200 researchers on staff.
COMPLETED SALE OF FIVE STAR-A.D.S SYSTEMS TO ALMASRIA UNIVERSAL AIRLINES
Announced that AlMasria Universal Airlines of Egypt has decided to
proceed with the installation and activation of the STAR-A.D.S.® System
across all five (5) of its current aircraft fleet, which includes A-320,
A-321, A330 and B737 aircraft.
BOMBARDER JOINT RESEARCH AND DEVELOPMENT PROGRAM
Joint research and development program with Bombardier and other
industrials and universities of Canada is progressing very positively.
The STAR-A.D.S. ® system which is at the heart of the program, after
having been validated and extensively used by the aircraft
manufacturer, has now been transferred to another flight test vehicle to
complete the flight testing and the data collection.
EMERGENCY MEDICAL SERVICES APPLICATIONS
Star’s Land System Aided Medical Monitoring system for ground
ambulance applications has undergone a series of demonstrations by a
care organization in North America.
Its airborne parent system, the In-Flight System Aided Medical
Monitoring system (STAR-ISAMM™â€), has now been demonstrated to several
stakeholders of the commercial and civil air ambulance market.
CHECK OUT OUR RECENT INTERVIEW
FULL DISCLOSURE: Star Navigation Systems Group Ltd. is an advertising client of AGORA Internet Relations Corp.
Posted by AGORACOM-JC
at 11:25 AM on Thursday, February 21st, 2019
Investment Highlights
Kenbridge property has a measured and indicated resource of 7.14 million tonnes at 0.62% nickel, 0.33% copper
17.5 (21.8 fully diluted) percent equity stake in Eloro Resources and 2 percent NSR in their La Victoria property
Kenbridge Ni Project (ON, Canada)
Advanced stage deposit remains open in three directions, is
equipped with a 623m deep shaft and has never been mined.
Preliminary Economic Assessment completed and updated returned robust project economics and operating costs including a NPV of C$253M and cash costs of US$3.47/lb of nickel net of copper credits.
Plans for Kenbridge include updating PEA,
advancing the project through to feasibility and exploring the open
mineralization at depth
FULL DISCLOSURE: Tartisan Nickel Corp. is an advertising client of AGORA Internet Relations Corp.
CardioComm Solutions’ HeartCheck(TM) Device Enters Final FDA Review Phase Read More
Completed a request for additional information from the US Food and
Drug Administration (“FDA”) for the Company’s premarket notification
510(k), Class II medical device clearance application for the
HeartCheck™ CardiBeat and GEMS™ Mobile Application.
Company had submitted a letter of revocation of their supplementary
information submission on December 26, 2018 in compliance with the FDA’s
directive
CardioComm Solutions’ HeartCheck(TM) CardiBeat and Smart Phone App Enter Final Stage of FDA 510(k) Review Read More
Market Release of HeartCheck(TM) CardiBeat and GEMS(TM) Mobile Application Set For Early 2019
Completed its response to the USA Food and Drug Administration for
additional information following the Company’s filing of its premarket
notification 510(k)
Class II medical device clearance application for the HeartCheck™ CardiBeat and GEMS™ Mobile Application
HeartCheck™ CardiBeat is the second of several planned Bluetooth-enabled ECG recording devices to be marketed by the Company
Launched 12-Lead ECG Smart Wearable Garment Monitoring Solution Read More
Announced joint partnership sales plans for the commercial launch of
its newest software release designed to support an innovative and easy
to use wireless, 12 lead ECG, vital signs, arrhythmia and ischemia
monitoring wearable smart garment manufactured by Israel-based
HealthWatch Technologies Ltd.
Products
The Project: Arrhythmia Screening and Medical Adherence
An Innovator in the Mobile ECG Industry
Company Accolades
FULL DISCLOSURE: CardioComm Solutions Inc. is an advertising client of AGORA Internet Relations Corp.
Posted by AGORACOM-JC
at 11:40 AM on Thursday, February 14th, 2019
WHY NORTHBUD FARMS?
Canadian regulatory door for CIP (Cannabinoid Infused Products) is opening this year As shown in other legal jurisdictions (Colorado, Washington, Nevada, California)
Infused products sector has become the highest margin segment of the industry
Positioned to be a raw input producer for this space
Currently working with multiple food,
beverage and science companies to provide safe standardized cannabinoid
infused raw inputs for large scale GMP manufacturing of products
Announced Creation of “1017†Distribution and Signing of a LOI to Acquire Janey’s Cannabis Line
THE OPPORTUNITY
Acquired late stage ACMPR applicant GrowPros MMP from Tetra Bio-Pharma (TSXV: TBP)
GrowPros MMP application was submitted in November 2014 and is currently in the ‘Confirmation of Readiness’ stage.
Announced the amendment of its licence application to add 500K SQ. FT. of outdoor cultivation area